<DOC>
	<DOCNO>NCT01567592</DOCNO>
	<brief_summary>Low intensity shockwaves proven animal study induce local growth new blood vessel exist one . The hypothesis study shockwave therapy could improve symptom patient refractory angina amenable revascularization angioplasty bypass surgery .</brief_summary>
	<brief_title>Extracorporeal Shockwave Therapy Treatment Chronic Angina Pectoris</brief_title>
	<detailed_description>Low intensity shockwaves ( 1/10 one use Lithotripsy ) deliver myocardial ischemic tissue . Shockwaves create special generator focus use shockwave applicator device . The treatment guide standard echocardiography equipment . The shockwaves deliver synchronization Patient R-wave avoid arrhythmia . The treatment painless . At first , patient undergoes stress- SPECT test identify ischemic area . Following , area localize ultra-sound device shockwaves focus ischemic area . Several treatment require optimal result .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>Inclusion Criteria 1 . The patient acoustic window myocardium echocardiography . 4 chamber view ( 4CH ) , 2 chamber view ( 2CH ) , long axis ( LAX ) short axis view ( SAX ) verify . 2 . Patient diagnose chronic angina pectoris . Diagnosis base medical history , complete physical evaluation , Exercise SPECT . 3 . Patient document myocardial reversible ischemia hibernation least one segment . 4 . Patient classify AP CCS III IV . 5 . Patient stable dosage medication use treat angina least 6 week prior enrollment . 6 . Patients demonstrate exercise tolerance time ( ETT ) duration &lt; 10 minute modify Bruce protocol 2 consecutive test ( test less 24 hour 2 week apart ) , second test within difference 25 % first ( Patients inform exercise restriction require entry study ) . 7 . Patients angioplasty bypass indicate anatomical procedural reason frequent reocclusion/restenosis follow traditional revascularization . 8 . Patient refuse undergo another angioplasty CABG . 9 . Patient sign informed consent form . 10 . Patient 's condition stable life expectancy &gt; 12 month . 11 . Patient 's current past medical condition status assess use previous medical history , physical evaluation , physician ( principle investigator 's ) medical opinion . Exclusion Criteria 1 . Patient chronic lung disease base GOLD criterion patient stage IV : Very Severe COPD accord Spirometric Classification COPD , Severity base PostBronchodilator 2 . Patient emphysema pulmonary fibrosis . 3 . Patient active endocarditis , myocarditis pericarditis . 4 . Patient simultaneously participate another device drug study , participate clinical trial involve experimental device drug , include drug device enhance cardiac neovascularization , treat TMR ( Transmyocardial revascularization ) PMR ( Percutaneous revascularization ) , ESWT machine neovascularization competitor company within 3 month entry study . 5 . Patients unwilling unable cooperate study procedure . 6 . Patients unwilling quit smoking study procedure ( include screen phase ) 7 . Patients MI le 3 month prior treatment 8 . Patients moderately severe severe valvular disease . Moderatelysevere severe disease echographically diagnose follow : Aortic Stenosis : Patients Moderatelysevere [ Peak Aortic valve gradient ( AVG ) : 5060 mmHg ; Mean AVG : 3040 mmHg ; Effective orifice area ( EOA ) : 0.751.0 cm2 ] severe Aortic Stenosis [ Peak AVG : 60 mmHg ; Mean AVG : 40 mmHg ; EOA : 0.75 cm2 ] Mitral Stenosis : Patients severe Mitral Stenosis [ EOA : 1 cm2 ; Pressure halftime ( m ) : 200 mmHg ; Mean Mitral valve gradient : 10 mmHg ] Aortic Regurgitation &amp; Mitral Regurgitation : Patients moderately severe severe aortic regurgitation mitral regurgitation exclude . Moderatelysevere ( grade 3 , 3/4 ) severe ( grade 4 , 4/4 ) hemodynamically significant . Tricuspid Regurgitation ( TR ) : Its severity grade 14 aortic mitral regurgitation . Grades 3 4 exclude study . The severe level TR common severe biventricular failure , mitral stenosis , cor pulmunale cause pulmonary hypertension . 9 . Patient intraventricular thrombus 10 . Patient pregnant 11 . Patient malignancy area treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Extracorporeal Shockwave Therapy</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Refractory Angina</keyword>
</DOC>